skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

世界の医療機器・医療技術に関する最新情報

Medtech Insight(メドテックインサイト)では、世界の医療機器・医療技術に関する最新の開発状況(臨床試験の結果、承認審査、市販後の更新情報等)や投資動向、ディール活動、参入企業の動きなど医療機器・医療技術産業全体の最新情報をお伝えします。

欧州、米国、アジアの各地に拠点を置く経験豊富なジャーナリスト&アナリストが、独自の分析と業界のオピニオンリーダーの考えを交えてニュースをお伝えします。FDAの警告書をモニターするMedtech Insight trackerにもアクセスできます。

下記のようなニーズにお応えします

  • 世界中の医療機器・医療技術の動きをフォローしたい
  • 競合企業の動きをチェックしたい
  • ライセンス導入/導出、投資、提携、M&Aの機会を探したい
  • 医療機器・医療技術のグローバルな薬事規制や承認審査の最新情報を常に把握したい

 

Medtech Insightのページにアクセスすると、各記事の冒頭部分のみご覧になれます。お気軽に無料トライアルもお試しください。


このサービスの特徴

無料の最新記事&レポート

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...

    Q4 2019 Outlook Report Extract

    16 Oct 2019

    What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.

    Topic clinical-trials drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Q3 2019 Catalyst Roundup

    16 Oct 2019

    What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.

    Topic Drug approval Drug review FDA

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...

    Key potential drug launches 2020

    27 Sep 2019

    Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.

    Topic drug-approval drug-review drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker: Improved Custom Company Portfolio Feature

    04 Sep 2019

    Discover how creating custom company portfolios can help you overcome your toughest business challenges. 

    Topic business-strategies

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker Q3 2019 Outlook Report Extract

    29 Jul 2019

    In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.   

    Topic Drug development landscape Drug review Research Strategy

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    2019 Q3 Outlook Webinar

    15 Jul 2019

    Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

    Topic immuno-oncology Infectious diseases

  • Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...

    When Part of the Picture Isn't Enough

    05 Jul 2019

    Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and difficult to find, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your fingertips, saving you time and effort. The new “Associated Products” section on relevant Biomedtracker Drug Profile pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.

    Topic business-strategies medtech

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

    By Michael ​ Haydock 02 Jul 2019

    Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

    Topic drug-approval drug-development-landscape drug-review

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker: Catalyst Roundup 2018 Q4

    02 Jul 2019

    A Review of Select Catalysts from Last Quarter’s Outlook Report.

    Topic clinical-trials drug-approval drug-review drug-development-landscape

  • Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...

    Q2 2019 Outlook Report

    03 May 2019

    In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

    Topic drug-approval drug-development-landscape drug-review

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...

    December 2018 National Influenza Week

    10 Apr 2019

    3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

    Topic influenza-virus infectious-diseases

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker 2018 Early Outlook Report

    10 Apr 2019

    What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...

    Biomedtracker: Early 2019 Outlook Report Extract

    10 Apr 2019

    In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

    Topic drug-approval drug-review medtech

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

    19 Nov 2018

    Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

    Topic Drug development landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker Q4 2018 Outlook Report

    19 Oct 2018

    Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

    Topic drug-development-landscape

医薬品産業専門のジャーナリスト&アナリスト

Editor

Amanda Maxwell

Editor, European Regulatory Affairs Editor
Amanda Maxwell

Amanda specializes in

  • Diagnostics
  • Medical Devices
  • Medtech
  • Policy & Regulation

+35 year(s) experience

Management

Ian Haydock

Management, Editor In Chief, Pharma, APAC
Ian Haydock

無料トライアル&お問い合わせ

ニュースサービスでは無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。